Tag: CereVasc

CereVasc receives approval to initiate first-in-human clinical study of the eShunt...

CereVasc announced today that Argentina's National Administration of Drugs, Foods and Medical Devices (ANMAT) approved the company's request to conduct a clinical study titled...